Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A systematic review and a prototype of an adapted model of care. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104329. doi: 10.1016/j.critrevonc.2024.104329. Epub 2024 Mar 26

2024
ASL Cuneo 2

Tipo pubblicazione

Systematic Review

Autori/Collaboratori (24)Vedi tutti...

?niadecki M
Department of Gynaecology and Obstetrics, Medical University of Gda?sk, Gda?sk, Poland. Electronic address: marcinsniadecki@gumed.edu.pl.
Guani B
Hospital of Fribourg HFR, Chemin des Pensionnats 2/6, Villars-sur-Glâne 1752, Switzerland.
Jaworek P
Department of Gynaecology and Obstetrics, Medical University of Gda?sk, Gda?sk, Poland.

et alii...

Abstract

PURPOSE: We found a need for balancing the application of clinical guidelines and tailored approaches to follow-up of cervical cancer (CC) patients in the lymph node micrometastatic (MICs) setting. This review aimed to determine the current knowledge of management of MIC-positive CC cases. METHODOLOGY: We addressed prognostic and risk of recurrence monitoring impacts associated with MIC+ cases. The electronic databases for literature and relevant articles were analysed. RESULTS: Fifteen studies, (4882 patients), were included in our systematic review. While the results show that MICs significantly worsen prognosis in early CC. A tertiary prevention algorithm for low volume lymph node disease may stratify follow-up according to the burden of nodal disease and provide data that helps improve follow-up performance. CONCLUSION: MICs worsen prognosis and should be managed as suggested by the algorithm. However, this algorithm must be externally validated. The clinical impact of isolated tumor cells (ITC) remains unclear.

Accesso banca dati bibliografica

Accedi alla scheda bibliografica del documento in PUBMED

Se sei accreditato in BVS-P effettua prima l'accesso per utilizzare i nostri servizi.

PMID : 38527594

DOI : 10.1016/j.critrevonc.2024.104329

Keywords

Female; Humans; Lymph Nodes/pathology; Lymphatic Metastasis; Neoplasm Micrometastasis/pathology; Neoplasm Recurrence, Local/prevention & control/pathology; Prognosis; Tertiary Prevention/methods; Uterine Cervical Neoplasms/pathology/diagnosis/prevention & control; Algorithm; Cervical cancer; Micrometastasis; Prevention; Review; Sentinel lymph node;